HBO Kennisbank

4 Resultaten

Sorteer op:

Dysphagia, trismus and speech impairment following radiation-based treatment for advanced stage oropharyngeal carcinoma: a one-year prospective evaluation

Karsten, Rebecca T.; Chargi, Najiba; van der Molen, Lisette; van Son, Rob J. J. H.; de Bree, Remco; Al-Mamgani, Abrahim; de Boer, Jan P.; Hilgers, Frans J. M.; van den Brekel, Michiel W. M.; Smeele, Ludi E.; Stuiver, Martijn M. (Lectoraat Functioneel Herstel Bij Kanker)

OBJECTIVE: The objective was to assess swallowing, mouth opening and speech function during the first year after radiation-based treatment (RT(+)) after introduction of a dedicated preventive rehabilitation program for stage III-IV oropharyngeal carcinoma (OPC). METHODS: Swallowing, mouth opening and …

2022AlgemeenArtikel

Long-term swallowing, trismus, and speech outcomes after combined chemoradiotherapy and preventive rehabilitation for head and neck cancer; 10-year plus update

Karsten, Rebecca T.; van der Molen, Lisette; Hamming-Vrieze, Olga; van Son, RobJ. J. J. H.; Hilgers, Frans J. M.; van den Brekel, Michiel W. M.; Stuiver, Martijn M (Centre Of Expertise Urban Vitality); Smeele, Ludi E.

BACKGROUND: The objective of this study was to explore the 10-year plus outcomes of Intensity Modulated Radiotherapy with concomitant chemotherapy (CRT) combined with preventive swallowing rehabilitation (CRT+) for head and neck cancer (HNC). METHODS: Subjective and objective swallowing, trismus, and …

2020AlgemeenArtikel

Radiation dose to the masseter and medial pterygoid muscle in relation to trismus after chemoradiotherapy for advanced head and neck cancer

Sophie A. Kraaijenga; Olga Hamming-Vrieze; Sonja Verheijen; Emmy Lamers (Lid Lectoraat); Lisette van der Molen; Frans J. Hilgers; Michiel W. van den Brekel; Wilma D. Heemsbergen

Abstract Background: We studied the relationship between trismus (maximum interincisor opening [MIO] ≤35 mm) and the dose to the ipsilateral masseter muscle (iMM) and ipsilateral medial pterygoid muscle (iMPM). Methods: Pretreatment and post-treatment measurement of MIO at 13 weeks revealed 17% of …

2019GezondheidArtikel

Dose to the masseter muscle and risk of trismus after chemoradiation for advanced head & neck cancer

S Verheijen (Onderzoeker); Emmy Lamers (Lid Lectoraat)

Purpose / objective: Head and neck cancer patients treated with chemoradiation are at risk for developing trismus (reduced mouth opening). Trismus is often a persisting side-effect and difficult to manage. It impairs eating, speech and oral hygiene, affecting quality of life. Although several studies …

2015-12-01GezondheidAndersoortig materiaal

Vorige Volgende

Dysphagia, trismus and speech impairment following radiation-based treatment for advanced stage oropharyngeal carcinoma: a one-year prospective evaluation

Long-term swallowing, trismus, and speech outcomes after combined chemoradiotherapy and preventive rehabilitation for head and neck cancer; 10-year plus update

Radiation dose to the masseter and medial pterygoid muscle in relation to trismus after chemoradiotherapy for advanced head and neck cancer

Dose to the masseter muscle and risk of trismus after chemoradiation for advanced head & neck cancer

Over HBO Kennisbank